Progress on T lymphocyte subsets after lung transplantation

doi:10.3877/cma.j.issn.1674-3903.2019.02.016

Abstract

Abstract:

T lymphocytes are the main effector cells of the immune response after lung transplantation. The level of lymphocyte subsets has an important influence on the immune status of recipients after lung transplantation. This article summarizes the immunological mechanisms of CD4⁺ T cells, CD8⁺ T cells and regulatory T cells, as well as their roles in primary graft dysfunction, acute rejection, chronic rejection, immune tolerance and infection after lung transplantation. Finally, we discuss the clinical significance of detecting T lymphocyte subsets after lung transplantation.

Key words: Lung transplantation, T lymphocyte subsets, Regulatory T cell, Primary graft dysfunction

Qiaoyan Lian, Ao Chen, Chunrong Ju. Progress on T lymphocyte subsets after lung transplantation[J]. Chinese Journal of Transplantation(Electronic Edition), 2019, 13(02): 151-155.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhyzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3903.2019.02.016

https://zhyzzz.cma-cmc.com.cn/EN/Y2019/V13/I02/151

References 46

1	练巧燕，徐鑫，罗群，等. 肺移植治疗间质性肺疾病的疗效及预后影响因素分析[J]. 中国呼吸与危重监护杂志，2019，18(2): 134-139.
2	Costa J, Benvenuto LJ, Sonett JR. Long-term outcomes and management of lung transplant recipients[J]. Best Pract Res Clin Anaesthesiol, 2017, 31(2): 285-297.
3	李琼书，成先义，胡源，等. PLAC1特异性TCR基因修饰T细胞对乳腺癌的抗肿瘤作用[J/CD]. 中华细胞与干细胞杂志：电子版，2018, 8(2): 103-110.
4	Gauthier JM, Li W, Hsiao HM, et al. Mechanisms of graft rejection and immune regulation after lung transplant[J]. Ann Am Thorac Soc, 2017, 14(Suppl 3): S216-S219.
5	Yamada Y, Brüstle K, Jungraithmayr W. T helper cell subsets in experimental lung allograft rejection[J]. J Surg Res, 2019, 233: 74-81.
6	Liu Z, Fan H, Jiang S. CD4(＋) T-cell subsets in transplantation[J]. Immunol Rev, 2013, 252(1): 183-191.
7	Sabet-Baktach M, Eggenhofer E, Rovira J, et al. Double deficiency for RORgammat and T-bet drives Th2-mediated allograft rejection in mice[J]. J Immunol, 2013, 191(8): 4440-4446.
8	Methe H, Nanasato M, Spognardi AM, et al. T-helper 2 cells are essential for modulation of vascular repair by allogeneic endothelial cells[J]. J Heart Lung Transplant, 2010, 29(4): 479-486.
9	Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4^＋ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages[J]. Nat Immunol, 2005, 6(11): 1123-1132.
10	Gupta PK, Wagner SR, Wu Q, et al. IL-17A blockade attenuates obliterative bronchiolitis and IFN-gamma cellular immune response in lung allografts[J]. Am J Respir Cell Mol Biol, 2017, 56(6): 708-715.
11	Wu Q, Gupta PK, Suzuki H, et al. CD4 T cells but not Th17 cells are required for mouse lung transplant obliterative bronchiolitis[J]. Am J Transplant, 2015, 15(7): 1793-1804.
12	Walters GD, Vinuesa CG. T follicular helper cells in transplantation[J]. Transplantation, 2016, 100(8): 1650-1655.
13	Pinelli DF, Ford ML. Novel insights into anti-CD40/CD154 immunotherapy in transplant tolerance[J]. Immunotherapy, 2015, 7(4): 399-410.
14	刘畅，王红艳. CD8^＋T细胞活化与分化的分子机制[J]．中国免疫学杂志，2017, 33(4): 481-487.
15	Bueno V, Pestana JO. The role of CD8^＋ T cells during allograft rejection[J]. Braz J Med Biol Res, 2002, 35(11): 1247-1258.
16	Harper SJ, Ali JM, Wlodek E, et al. CD8 T-cell recognition of acquired alloantigen promotes acute allograft rejection[J]. Proc Natl Acad Sci USA, 2015, 112(41): 12788-12793.
17	Lendermon EA, Dodd-O JM, Coon TA, et al. CD8(＋)IL-17(＋) T cells mediate neutrophilic airway obliteration in T-bet-deficient mouse lung allograft recipients[J]. Am J Respir Cell Mol Biol, 2015, 52(5): 622-633.
18	Xu Z, Ho S, Chang CC, et al. Molecular and cellular characterization of human CD8 T suppressor cells[J]. Front Immunol, 2016, 7: 549.
19	Geng L, Liu J, Huang J, et al. A high frequency of CD8(＋)CD28(－) T-suppressor cells contributes to maintaining stable graft function and reducing immunosuppressant dosage after liver transplantation[J]. Int J Med Sci, 2018, 15(9): 892-899.
20	Hodge G, Hodge S, Ahern J, et al. Up-regulation of alternate co-stimulatory molecules on proinflammatory CD28 null T cells in bronchiolitis obliterans syndrome[J]. Clin Exp Immunol, 2013, 173(1): 150-160.
21	Martin-Moreno PL, Tripathi S, Chandraker A. Regulatory T cells and kidney transplantation[J]. Clin J Am Soc Nephrol, 2018, 13(11): 1760-1764.
22	Siemeni T, Knofel AK, Madrahimov N, et al. In vivo development of transplant arteriosclerosis in humanized mice reflects alloantigen recognition and peripheral Treg phenotype of lung transplant recipients[J]. Am J Transplant, 2016, 16(11): 3150-3162.
23	Salman J, Ius F, Knoefel AK, et al. Association of higher CD4(＋) CD25(high) CD127(low), FoxP3(＋), and IL-2(＋) T cell frequencies early after lung transplantation with less chronic lung allograft dysfunction at two years[J]. Am J Transplant, 2017, 17(6): 1637-1648.
24	Brunstein CG, Miller JS, Mckenna DH, et al. Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect[J]. Blood, 2016, 127(8): 1044-1051.
25	Zwang NA, Leventhal JR. Cell therapy in kidney transplantation: focus on regulatory T cells[J]. J Am Soc Nephrol, 2017, 28(7): 1960-1972.
26	Chambers DC, Yusen RD, Cherikh WS, et al. The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time[J]. J Heart Lung Transplant, 2017, 36(10): 1047-1059.
27	Gelman AE, Fisher AJ, Huang HJ, et al. Report of the ISHLT Working Group on primary lung graft dysfunction part Ⅲ: mechanisms: a 2016 consensus group statement of the International Society for Heart and Lung Transplantation[J]. J Heart Lung Transplant, 2017, 36(10): 1114-1120.
28	Morrison MI, Pither TL, Fisher AJ. Pathophysiology and classification of primary graft dysfunction after lung transplantation[J]. J Thorac Dis, 2017, 9(10): 4084-4097.
29	Whitson BA, Lehman A, Wehr A, et al. To induce or not to induce: a 21st century evaluation of lung transplant immunosuppression′s effect on survival[J]. Clin Transplant, 2014, 28(4): 450-461.
30	Gauthier JM, Hachem RR, Kreisel D. Update on chronic lung allograft dysfunction[J]. Curr Transplant Rep, 2016, 3(3): 185-191.
31	Royer PJ, Olivera-Botello G, Koutsokera A, et al. Chronic lung allograft dysfunction: a systematic review of mechanisms[J]. Transplantation, 2016, 100(9): 1803-1814.
32	Coiffard B, Pelardy M, Loundou AD, et al. Effect of immunosuppression on target blood immune cells within 1 year after lung transplantation: influence of age on T lymphocytes[J]. Ann Transplant, 2018, 23: 11-24.
33	Chen R, Liang F, Chen Q, et al. A novel model for dissecting roles of IL-17 in lung transplantation[J]. J Thorac Dis, 2018, 10(6): 3298-3307.
34	Hall BM. CD4^＋CD25^＋ T regulatory cells in transplantation tolerance: 25 years on[J]. Transplantation, 2016, 100(12): 2533-2547.
35	Durand M, Lacoste P, Danger R, et al. High circulating CD4(＋)CD25(hi)FOXP3(＋) T-cell sub-population early after lung transplantation is associated with development of bronchiolitis obliterans syndrome[J]. J Heart Lung Transplant, 2018, 37(6): 770-781.
36	Krupnick AS, Lin X, Li W, et al. Central memory CD8^＋ T lymphocytes mediate lung allograft acceptance[J]. J Clin Invest, 2014, 124(3): 1130-1143.
37	Calarota SA, Chiesa A, De Silvestri A, et al. T-lymphocyte subsets in lung transplant recipients: association between nadir CD4 T-cell count and viral infections after transplantation[J]. J Clin Virol, 2015, 69: 110-116.
38	Klenerman P, Oxenius A. T cell responses to cytomegalovirus[J]. Nat Rev Immunol, 2016, 16(6): 367-377.
39	Leyssens A, Dierickx D, Verbeken EK, et al. Post-transplant lymphoproliferative disease in lung transplantation: a nested case-control study[J]. Clin Transplant, 2017, 31(7): e12983.
40	Coiffard B, Pelardy M, Gomez C, et al. Kinetics of peripheral blood lymphocyte subsets in lung transplant recipients[J] . J Heart Lung Transplant, 2015, 34(4): S260.
41	Zeglen S, Laszewska A, Wojarski J, et al. Lymphocyte subtypes CD3^＋, CD19^＋, CD16^＋CD56^＋, CD4^＋, CD8^＋, and CD3^＋HLA-DR^＋ in peripheral blood obtained from patients after thoracic organ transplantation[J]. Transplant Proc, 2011, 43(8): 3055-3057.
42	张稷，徐东菁，郑明峰，等. 肺移植术后发生急性排斥反应者和感染者的外周血T淋巴细胞亚群检测[J]. 中华器官移植杂志，2008, 29(3): 182-183.
43	Mian M, Natori Y, Ferreira V, et al. Evaluation of a novel global immunity assay to predict infection in organ transplant recipients[J]. Clin Infect Dis, 2018, 66(9): 1392-1397.
44	Speck NE, Schuurmans MM, Benden C, et al. Plasma and bronchoalveolar lavage samples in acute lung allograft rejection: the potential role of cytokines as diagnostic markers[J]. Respir Res, 2017, 18(1): 151.
45	Gharib SA, Edelman JD, Ge L, et al. Acute cellular rejection elicits distinct microRNA signatures in airway epithelium of lung transplant patients[J]. Transplant Direct, 2015, 1(10): e44.
46	Dewolf S, Shen Y, Sykes M. A new window into the human alloresponse[J]. Transplantation, 2016, 100(8): 1639-1649.

[1]	Lung Transplantation Study Group, Branch of Organ Transplantation of Chinese Medical Association;, National Lung Transplantation Quality Control Center. Selection of lung transplant candidates with COVID-19: Advises from China lung transplant expert group [J]. Chinese Journal of Transplantation(Electronic Edition), 2023, 17(01): 13-16.
[2]	Jiaojie Hui, Fengming Liang, Yifeng Wang, Dapeng Wang, Jingyu Chen, Hongyang Xu. Experience in the management of drainage insufficiency on extracorporeal membrane oxygenation after lung transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2022, 16(04): 238-240.
[3]	Ting Wu, Yanyan Sun, Yuanyuan Zheng, Weili Han. Single lung transplantation in a bronchiectasis patient with ankylosing spondylitis [J]. Chinese Journal of Transplantation(Electronic Edition), 2022, 16(04): 235-237.
[4]	Qiang Guo, Song Tong, Chuangyan Wu, Chongrui Chen, Te Wu, Sihua Wang. The roles and potential mechanisms of differential genes in lung transplantation ischemia-reperfusion injury based on geno expression omnibus database [J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(06): 353-358.
[5]	Jin Zhao, Jingyu Chen. Clinical research progress of combined liver and lung transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(05): 298-302.
[6]	Sichao Gu, Min Li, Run Tong, Qingyuan Zhan. Distribution characteristics of lung pathogens and strategies of prophylactic antibiotics in lung transplant donors and recipients during operation and 48 hours after operation [J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(05): 282-285.
[7]	Hua Liu, Yajun Chen, Jianping Gong. Immune induction and therapeutic effects of regulatory T cells in liver transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(04): 239-243.
[8]	Wei Xia, Hongyang Xu, Wenjun Mao, Jingyu Chen. Application of extracorporeal membrane oxygenation in the perioperative period of lung transplantation [J]. Chinese Journal of Transplantation(Electronic Edition), 2021, 15(04): 199-204.
[9]	Shuang Xia, Min Cao, Xiang Xi. Effects of retroperitoneal laparoscopic partial nephrectomy on serum T lymphocyte subsets and prognosis and survival in elderly patients with T1b stage renal cell carcinoma [J]. Chinese Journal of Endourology(Electronic Edition), 2021, 15(05): 406-410.
[10]	Xiaoqin Weng, Jiayang Qin, Yang Zhang, Jin Cui, Hong Shen. Effect of HIF-1α/VEGF-VEGFR2/Nrp-1 on Treg proliferation in NSCLC patients [J]. Chinese Journal of Lung Diseases(Electronic Edition), 2021, 14(06): 717-722.
[11]	Jingen Xia, Shiyu Hu. Application scenario of extracorporeal carbon dioxide removal technology in Intensive Care Unit [J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2023, 09(01): 40-45.
[12]	Yongqing Han, Minchao Rao, Feng Fu, Kairong Huang. Shenqishiyiwei granules combined with FOLFOX4 chemotherapy for treatment of patients with advanced colorectal cancer: short-term efficacy and effect on serum IL-35, IL-37, and T lymphocyte subsets [J]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(05): 400-404.
[13]	Ning Li, Yan Liu, Huiqing Lin. Mechanism and prevention of ischemia-reperfusion injury of donor lung transplantation [J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2023, 10(04): 247-256.
[14]	Chunguang Li, Zhigang Li. Research progress of donor lung maintenance strategy in lung transplantation [J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2022, 09(02): 75-79.
[15]	Wentao Fang. From refined technology to redefining ideology—introduction to the Issue 1 of Chinese Journal of Thoracic Surgery (Electronic Edition) in 2022 [J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2022, 09(02): 109-110.

Please choose a citation manager

Content to export